Scaling beyond limited early-stage momentum often calls for a disciplined corporate turnaround strategy. Jake Burlet outlines the practical steps CanBiocin took to shift from grant-to-grant R&D survival to a profitable growing enterprise through securing strategic investment.
Session Topics:
2022 Showcase Finalist
Nutrition
Companion and Livestock
Microbiome
Prevention
Series B
Milestone - Corporate Turnaround
Speaker(s):
Jake Burlet
CEO
CanBiocin
Time:
12:40pm - 1:00pm
Agenda Track No.:
Track 2
Summary:
Session Will be Recorded - Attend live or Watch On-Demand
Session Type:
General Session (Presentation)